New Rapid-acting Antidepressants / Contemporary Clinical Neuroscience (PDF)
(Sprache: Englisch)
This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such...
sofort als Download lieferbar
eBook (pdf)
Fr. 212.50
inkl. MwSt.
- Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „New Rapid-acting Antidepressants / Contemporary Clinical Neuroscience (PDF)“
This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area. In this volume, a variety of novel pharmaceutical treatments are examined. This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments.
Discusses new candidate for rapid-acting antidepressants
Provides information for those who work in the field of CNS drugs
Ideal for pharmacologists, psychiatrists, and those who want to learnabout CNS drugs at the graduate level
Autoren-Porträt
First Name - Kenji Last Name - Hashimoto
Institution - Chiba University Center for Forensic Mental Health
Department - Division of Clinical Neuroscience
City - Chiba 260-8670
State - Chiba
Country - Japan
Email - hashimoto@faculty.chiba-u.jp
Kenji Hashimoto, PhD
Chiba University, Chiba, Japan
Dr. Hashimoto is a professor and vice-director of Chiba University Center for Forensic Mental Health from 2005. Dr. Hashimoto graduated from Faculty of Pharmaceutical Sciences at Kyushu University, and received PhD. After Dr. Hashimoto worked at Fukuyama University, National Institutes of Health (NIH)/National Institute of Drug Addiction (NIDA)(Baltimore, MD, USA) and Pharmaceutical company, he moved at Chiba University Graduate School of Medicine from 2001. Dr. Hashimoto works on the development of novel therapeutic drugs for psychiatric and neurological disorders. Dr. Hashimoto published more than 550articles in PubMed listed publications. Dr. Hashimoto focus on the molecular and cellular mechanisms of ketamine's antidepressant actions.
Bibliographische Angaben
- 2021, 1st ed. 2021, 149 Seiten, Englisch
- Herausgegeben: Kenji Hashimoto, Mario Manto
- Verlag: Springer International Publishing
- ISBN-10: 3030797902
- ISBN-13: 9783030797904
- Erscheinungsdatum: 22.10.2021
Abhängig von Bildschirmgrösse und eingestellter Schriftgrösse kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Grösse: 3.59 MB
- Ohne Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kommentar zu "New Rapid-acting Antidepressants / Contemporary Clinical Neuroscience"
0 Gebrauchte Artikel zu „New Rapid-acting Antidepressants / Contemporary Clinical Neuroscience“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "New Rapid-acting Antidepressants / Contemporary Clinical Neuroscience".
Kommentar verfassen